Immunofluorescence Assay Market Size, Growth, Statistics, Competitor Landscape, Company Profiles and Business Trends


The global immunofluorescence assay market is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases

The global immunofluorescence assay market is growing pervasively. The market growth attributes to the increase in biological studies in RD for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.

With the intervention of the COVID-19, the immunofluorescence assay industry is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global immunofluorescence assay market size is projected to register 5.8% CAGR during the analysis period (2020–2027).

Progressions in clinical innovation, close by the rising RD financing by industry pioneers and states, support the market development. Also, rising quantities of preclinical examination, close by the rising investigations on immune response treatments, progressed drug disclosures, and oncology infections, speed up the market development. Developing coordinated efforts between research foundations and biotechnology organizations are relied upon to drive the development of the immunofluorescence assay market.

Then again, the significant expense of immunofluorescence assay items, for example, indicative packs is relied upon to confine the market development during the conjecture time frame. Additionally, factors like dangers of cross pollutions and lack of gifted work and powerless discovery signals are assessed to hinder the development of this market. In any case, developing headways in biotechnology and clinical science would uphold the development of the market, achieving practical immunofluorescence assay.

Request Free Sample Copy at:


Global Immunofluorescence Assay Market – Segmentation

The report is segmented into five dynamics; 

By Technique : Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence.

By Product Type          : Antibodies, Kits Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others.

By Application              : Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research Development, and others.

By End-User                   : Biotechnology Companies, Hospitals Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions                     :  Americas, Europe, Asia Pacific, and Rest-of-the-World.



Global Immunofluorescence Assay Market – Regional Analysis

North America rules the worldwide immunofluorescence assay market size. The biggest market share ascribes to the high commonness of constant illnesses and rising RD speculations inside this district. Additionally, the rising reception of cutting edge frameworks for early conclusion of sicknesses drives the provincial market development. In addition, the progression in the advancement strategies and expanding utilization of nanotechnology in the improvement of immunofluorescence assay cultivated the development of the local market.

The US, among other North American nations, holds the biggest offer in the territorial market. Plus, the presence of tremendous quantities of biotechnology and drug organizations impacts the local market development decidedly. The North American immunofluorescence assay market is assessed to hold its driving situation all through the appraisal period.

Europe stands second in the immunofluorescence assay market size. The market is driven by the rising predominance of hordes of ongoing infections like malignant growth and the quickly developing biotechnology area in Europe. In addition, significant RD ventures by the general population and private areas, close by the rising R and D in biotechnology, encourage the market development in the district. The European immunofluorescence assay market is projected to make a significant income pocket over the survey time frame.

The immunofluorescence assay market size in the Asia Pacific district is developing quickly. Factors like the developing patient pool, high frequency of ongoing sicknesses, creating medical care foundation, and expanding RD exercises in the biotechnology area impact the market around here. Additionally, the presence of significant market players in China, India, and Japan drive market development. Rising government drives increment the size of the immunofluorescence assay market in the district.

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period.

Global Immunofluorescence Assay Market – Competitive Analysis

Highly competitive, the global immunofluorescence assay market size appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for RD and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market. 

Major Players: 

Players leading the global immunofluorescence assay market include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others. 

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071




168 Blog posts